Since 1990, helping busy clinicians master the science and art of caring for people with HIV disease.

PRN Member Menu

Due to the COVID-19 pandemic, all meetings are now via the Zoom Webinar platform.
Pre-Register Here
Please help PRN by taking the pre-meeting evaluation. These surveys are critical to the future of our programs and accreditation.
Pre-Meeting Survey
MEETING AND CME INFORMATION

PRN Meeting: May 12, 2021 Jointly provided by the Medical Society of the State of New York, at a Zoom webinar, 7:00 p.m. to 9:00 p.m (EST).

Target Audience:

Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.

Course Director: James F. Braun, DO, President, Physicians' Research Network

Course Moderator: William M. Valenti, MD, Chair, Infectious Diseases Committee of the Medical Society of the State of New York

Guest Speakers and Presentations:

HIV-1 bNAbs: Looking Ahead

Marina Caskey, MD

Professor of Clinical Investigation
The Rockefeller University, New York, NY

Marina Caskey provides a comprehensive update of broadly neutralizing antibodies (bNAbs) in the treatment and prevention of HIV.  Learn the latest on outcomes from recent engineered HIV bNAbs clinical trials, prevention efficacy studies, as well as new HIV bNAb delivery systems entering clinical evaluation.

Learning Objectives:

At the completion of this educational session, participants will:
1. Know about new anti-HIV broadly neutralizing antibodies in clinical development.
2. Understand results from two prevention efficacy studies (AMP trials) with VRC01, an HIV bNAb.
3. Be aware of recent clinical trials of engineered HIV bNAbs.
4. Know about new delivery systems of HIV bNAbs that are entering clinical evaluation.

Got anything for the Cough? Treatments for Early COVID-19

Davey Smith, MD

Chief, Division of Infectious Diseases and Global Public Health
Co-Director, San Diego Center for AIDS Research (CFAR)
Professor of Medicine, University of California San Diego

Despite the vaccine roll-out, new cases of COVID-19 persist; hence we still need to understand and optimize the treatments available to us, as well as those in development.  In this comprehensive presentation,  Davey Smith discusses current treatments as well antiviral drugs in development for COVID-19.

Learning Objectives:

At the completion of this educational session, participants will:
1. The natural history of COVID-19
2. Monoclonal antibody therapies and their indications under an EUA
3. Other antiviral therapies under investigation.

Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). The Medical Society of the State of New York (MSSNY) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing Medical Education for physicians.

The Medical Society of the State of New York (MSSNY) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:

Dr. Braun (Planner/Course Director) has no relevant financial relationships to disclose. Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose. Dr. Marina Caskey (Presenter) has no relevant financial relationships to disclose. Dr. Caskey will support her presentation and clinical recommendations with the best available evidence from the medical literature and will submit her slides in advance for adequate peer review. Dr. David M. Smith (Presenter) has no relevant financial relationships to disclose. Dr. Smith will support his presentation and clinical recommendations with the best available evidence from the medical literature and will submit his slides in advance for adequate peer review.

Financial Support:

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

PRN Member Menu

Are you a member? If so, please log-in.

Not a member? Please register.

Have you forgotten your password?